2021 -now Founder and CEO @ Etheros Pharmaceuticals
2014 -now Founder and MD @ JW Scannell Analytics LTD
2016 -2019 Co-head of Pharmaceuticals - Equity Research @
2013 -2014 Head of Discovery Research @
2005 -2012 Head of European Healthcare @
2000 -2005 Management consultant @
1995 -1999 University Lecturer @ Neural Systems Group, Newcastle University
1991 -1995 Researcher in Computational Neuroscience and Systems Neuroscience @ University of Oxford, Department of Physiology
Jack Scannell Education
Oxford University
Doctor of Philosophy (Philosophy, Neuroscience)
1991-1995
Trinity College, Cambridge University
(Zoology)
1986-1989
Jack Scannell Skills
Molecular Biology
Equity Research
Financial Modeling
Network Pharmacology
Lifesciences
Data Analysis
Due Diligence
Biotechnology
Valuation
Computational Neuroscience
Bioinformatics
Systems Biology
Life Sciences
R&D
Equities
Drug Discovery
Jack Scannell Summary
Jack Scannell, based in Edinburgh, GB, is currently a Venture Director at Hiro Capital. Jack Scannell brings experience from previous roles at Etheros Pharmaceuticals, JW Scannell Analytics LTD, UBS and e-Therapeutics PLC. Jack Scannell holds a 1991 - 1995 Doctor of Philosophy in Philosophy, Neuroscience @ Oxford University. With a robust skill set that includes Molecular Biology, Equity Research, Financial Modeling, Network Pharmacology, Lifesciences and more. Jack Scannell has 1 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.